Literature DB >> 8565855

Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos.

R Spörle1, T Günther, M Struwe, K Schughart.   

Abstract

The differentiation of somite derivatives is dependent on signals from neighboring axial structures. While ventral signals have been described extensively, little is known about dorsal influences, especially those from the dorsal half of the neural tube. Here, we describe severe phenotypic alterations in dorsal somite derivatives of homozygous open brain (opb) mutant mouse embryos which suggest crucial interactions between dorsal neural tube and dorsal somite regions. At Theiler stage 17 (day 10.5 post coitum) of development, strongly altered expression patterns of Pax3 and Myf5 were observed in dorsal somite regions indicating that the dorsal myotome and dermomyotome were not differentiating properly. These abnormalities were later followed by the absence of epaxial (dorsal) musculature; whereas, body wall and limb musculature formed normally. Analysis of Mox1 and Pax1 expression in opb embryos revealed additional defects in the differentiation of the dorsal sclerotome. The observed abnormalities coincided with defects in differentiation of dorsal neural tube regions. The implications of our findings for interactions between dorsal neural tube, surface ectoderm and dorsomedial somite regions in specifying epaxial musculature are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565855     DOI: 10.1242/dev.122.1.79

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  2 in total

1.  The open brain (opb) mutation maps to mouse chromosome 1.

Authors:  T Günther; R Spörle; K Schughart
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

2.  Loss of abdominal muscle in Pitx2 mutants associated with altered axial specification of lateral plate mesoderm.

Authors:  Diana Eng; Hsiao-Yen Ma; Jun Xu; Hung-Ping Shih; Michael K Gross; Chrissa Kioussi; Chrissa Kiouss
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.